These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2125544)

  • 1. Clinical experience with the progestogen-only pill.
    Broome M; Fotherby K
    Contraception; 1990 Nov; 42(5):489-95. PubMed ID: 2125544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen.
    Wilson ES; Cruickshank J; McMaster M; Weir RJ
    Br J Obstet Gynaecol; 1984 Dec; 91(12):1254-60. PubMed ID: 6440589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with ethynodiol diacetate and mestranol as an oral contraceptive.
    Gidwani GP; Purandare BN
    J Obstet Gynaecol India; 1968 Apr; 18(2):287-93. PubMed ID: 12331821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of fertility with oral medication.
    Diddle AW; Watts GF; Gardner WH; Williamson PJ
    West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contraception with progestagens in systemic lupus erythematosus.
    Mintz G; Gutiérrez G; Delezé M; Rodríguez E
    Contraception; 1984 Jul; 30(1):29-38. PubMed ID: 6434228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.
    Akerlund M; Røde A; Westergaard J
    Br J Obstet Gynaecol; 1993 Sep; 100(9):832-8. PubMed ID: 8218004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oral contraception on water-suppressed proton NMR spectra of plasma.
    Carlier PG; Vaesen F; Gilles RG; Fradin EA; Rorive GL
    Magn Reson Med; 1991 Jan; 17(1):269-73. PubMed ID: 1648654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pill-a-month as an oral contraceptive.
    Hefnawi F; Hassanein M; Younis N
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):1-17. PubMed ID: 12256024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progestins and oral contraceptive-induced lipoprotein changes: a prospective study.
    Lipson A; Stoy DB; LaRosa JC; Muesing RA; Cleary PA; Miller VT; Gilbert PR; Stadel B
    Contraception; 1986 Aug; 34(2):121-34. PubMed ID: 3096633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical studies with a low dose estrogen-progestogen combination.
    Sartoretto JN; Ortega-Recio JC; Moraes R; Filho FN
    Contraception; 1977 May; 15(5):563-70. PubMed ID: 880827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of Norinyl 1/35 versus Lo-Ovral in Ile-Ife Nigeria.
    Ayangade O; Akinyemi A
    Int J Gynaecol Obstet; 1989 Oct; 30(2):165-70. PubMed ID: 2572488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of two low-dose combined oral contraceptives: results from a multicenter trial.
    Dunson TR; McLaurin VL; Israngkura B; Leelapattana B; Mukherjee R; Perez-Palacios G; Saleh AA
    Contraception; 1993 Aug; 48(2):109-19. PubMed ID: 8403908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on ovarian function in users of the progestagen only contraceptive pill.
    Tayob Y; Guillebaud J; Adams J; Jacobs HS
    J Obstet Gynaecol (Lahore); 1986 Apr; 6 Suppl 2():S91-5. PubMed ID: 12315277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
    Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
    N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceptability of injectable contraceptives in Assiut, Egypt.
    Salem HT; Salah M; Aly MY; Thabet AI; Shaaban MM; Fathalla MF
    Contraception; 1988 Dec; 38(6):697-710. PubMed ID: 2975583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I comparative clinical trial with subdermal implants--bioabsorbable levonorgestrel or norethisterone pellet fused with cholesterol.
    Joshi UM; Joshi JV; Donde UM; Sankoli GM; Virkar KD; Saxena BN
    Contraception; 1985 Jan; 31(1):71-82. PubMed ID: 3921309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Norplant contraceptive implants: rods versus capsules.
    Pasquale SA; Brandeis V; Cruz RI; Kelly S; Sweeney M
    Contraception; 1987 Sep; 36(3):305-16. PubMed ID: 3119287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study on the efficacy and acceptability of two contraceptive pills administered by the vaginal route: an international multicenter clinical trial.
    Coutinho EM; de Souza JC; da Silva AR; de Acosta OM; Alvarez F; Brache V; Garza Flores J; Vasquez-Estrada L; Santo R; Bassol S
    Clin Pharmacol Ther; 1993 Jan; 53(1):65-75. PubMed ID: 8422744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phasic approach to oral contraceptives.
    Hale RW
    Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 2):1052-8. PubMed ID: 3118718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.